2024 Q2 Form 10-K Financial Statement

#000149315224015461 Filed on April 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2023 Q4 2023
Revenue $311.0K $1.368M $2.683M
YoY Change 33.29% 431.15% 154.63%
Cost Of Revenue $73.19K $348.1K $637.1K
YoY Change 22.34% 265.23% 60.95%
Gross Profit $237.8K $1.020M $2.046M
YoY Change 37.07% 528.68% 211.0%
Gross Profit Margin 76.47% 74.55% 76.25%
Selling, General & Admin $270.4K $360.2K $2.027M
YoY Change -12.41% 82.95% 169.81%
% of Gross Profit 113.7% 35.33% 99.11%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $57.35K $277.5K
YoY Change -21.85% -4.98%
% of Gross Profit 5.63% 13.57%
Operating Expenses $436.2K $417.6K $2.305M
YoY Change -62.65% 54.49% 59.85%
Operating Profit -$198.4K $602.0K -$259.3K
YoY Change -80.05% -656.81% -66.93%
Interest Expense $206.7K $320.0K
YoY Change 96.32% -73.88%
% of Operating Profit 34.33%
Other Income/Expense, Net $166.3K -$60.00 -$430.8K
YoY Change -341.26% -99.96% 5.08%
Pretax Income $809.5K -$690.1K
YoY Change -625.06% -42.21%
Income Tax
% Of Pretax Income
Net Earnings -$32.02K $809.5K -$690.1K
YoY Change -96.99% -625.06% -42.21%
Net Earnings / Revenue -10.29% 59.19% -25.72%
Basic Earnings Per Share $0.00 -$0.14
Diluted Earnings Per Share $0.00 $0.09 -$0.14
COMMON SHARES
Basic Shares Outstanding 8.815M shares 8.815M shares 5.056M shares
Diluted Shares Outstanding 8.815M shares 5.056M shares

Balance Sheet

Concept 2024 Q2 2023 Q4 2023
SHORT-TERM ASSETS
Cash & Short-Term Investments $318.4K $318.4K
YoY Change 769.58% 769.58%
Cash & Equivalents $69.44K $318.4K
Short-Term Investments
Other Short-Term Assets $19.91K $19.91K
YoY Change -10.58% -10.6%
Inventory
Prepaid Expenses
Receivables $314.7K $855.6K $855.6K
Other Receivables $0.00 $0.00
Total Short-Term Assets $402.2K $1.194M $1.194M
YoY Change 186.74% 419.49% 419.49%
LONG-TERM ASSETS
Property, Plant & Equipment $18.62K $138.5K $138.5K
YoY Change -87.58% -22.68% -22.68%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $871.7K $927.6K $3.000K
YoY Change -17.44% 13150.8% -57.14%
Total Long-Term Assets $871.7K $927.6K $927.6K
YoY Change -17.44% -23.38% -23.38%
TOTAL ASSETS
Total Short-Term Assets $402.2K $1.194M $1.194M
Total Long-Term Assets $871.7K $927.6K $927.6K
Total Assets $1.274M $2.122M $2.122M
YoY Change 6.5% 47.28% 47.28%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.884M $3.029M $3.029M
YoY Change -5.56% -1.98% -1.98%
Accrued Expenses $324.2K $265.6K $465.9K
YoY Change 101.97% 165.92% 95.7%
Deferred Revenue $62.99K $62.99K
YoY Change 0.0% 0.0%
Short-Term Debt $440.7K $575.1K $971.8K
YoY Change -33.28% -3.87% 21.35%
Long-Term Debt Due $440.7K $575.1K $575.1K
YoY Change -33.28% -3.87% -3.87%
Total Short-Term Liabilities $4.456M $5.422M $5.422M
YoY Change -12.28% 8.47% 8.47%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $161.0K $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $4.456M $5.422M $5.422M
Total Long-Term Liabilities $161.0K $0.00
Total Liabilities $4.617M $5.422M $5.422M
YoY Change -9.11% 8.47% 8.47%
SHAREHOLDERS EQUITY
Retained Earnings -$13.10M -$13.06M
YoY Change -3.96% 5.58%
Common Stock $881.00 $881.00
YoY Change 0.0% -99.49%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$3.343M -$3.300M -$3.300M
YoY Change
Total Liabilities & Shareholders Equity $1.274M $2.122M $2.122M
YoY Change 6.5% 47.28% 47.28%

Cashflow Statement

Concept 2024 Q2 2023 Q4 2023
OPERATING ACTIVITIES
Net Income -$32.02K $809.5K -$690.1K
YoY Change -96.99% -625.06% -42.21%
Depreciation, Depletion And Amortization $57.35K $277.5K
YoY Change -21.85% -4.98%
Cash From Operating Activities $667.7K $253.4K
YoY Change 6301.73% -223.08%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $51.59K
YoY Change
Cash From Investing Activities $0.00 $51.59K
YoY Change -100.0% -2726.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -556.0K -$23.17K
YoY Change -2143.93% -111.15%
NET CHANGE
Cash From Operating Activities 667.7K $253.4K
Cash From Investing Activities 0.000 $51.59K
Cash From Financing Activities -556.0K -$23.17K
Net Change In Cash 111.8K $281.8K
YoY Change 213.29% -9394266.67%
FREE CASH FLOW
Cash From Operating Activities $667.7K $253.4K
Capital Expenditures $0.00
Free Cash Flow $667.7K $253.4K
YoY Change 7783.12% -221.92%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
usd
CY2023 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023 dei Entity Central Index Key
EntityCentralIndexKey
0001637866
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
usd
CY2022 DGWR Gain Loss On Asset Disposal
GainLossOnAssetDisposal
usd
CY2023 DGWR Gain Loss On Settlement Of Note Payable
GainLossOnSettlementOfNotePayable
usd
CY2023 DGWR Stock Issued During Period Value Rounded Up Fractional Shares Issued In Connection With Reverse Split.
StockIssuedDuringPeriodValueRoundedUpFractionalSharesIssuedInConnectionWithReverseSplit.
usd
CY2022 DGWR Gain Loss On Asset Disposal
GainLossOnAssetDisposal
usd
CY2023 DGWR Gain Loss On Settlement Of Note Payable
GainLossOnSettlementOfNotePayable
usd
CY2022 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
usd
CY2023 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
CY2022 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
usd
CY2022 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
usd
CY2023 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
CY2023 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
CY2023 DGWR Issuance Of Series B Convertible Preferred Stock In Partial Satisfaction Of Note Payable To Ceo
IssuanceOfSeriesBConvertiblePreferredStockInPartialSatisfactionOfNotePayableToCeo
usd
CY2023 DGWR Accrued Interest And Charges
AccruedInterestAndCharges
usd
CY2023 DGWR Issuance Of Common Stock In Satisfaction Of Deferred Compensation
IssuanceOfCommonStockInSatisfactionOfDeferredCompensation
usd
CY2023 DGWR Due To Seller Of Lyell Recognized And Added To Goodwill
DueToSellerOfLyellRecognizedAndAddedToGoodwill
usd
CY2023 DGWR Issuance Of Common Stock To Officers For Accrued Compensation
IssuanceOfCommonStockToOfficersForAccruedCompensation
usd
CY2023 DGWR Issuance Of Common Stock In Satisfaction Of Loans Payable To Officers
IssuanceOfCommonStockInSatisfactionOfLoansPayableToOfficers
usd
CY2022 DGWR Fair Value Of Shares Of Common Stock Issued
FairValueOfSharesOfCommonStockIssued
usd
CY2022 DGWR Accounts Payable Satisfied
AccountsPayableSatisfied
usd
CY2022 DGWR Loss On Satisfaction Of Accounts Payable
LossOnSatisfactionOfAccountsPayable
usd
CY2023Q4 us-gaap Property Plant And Equipment Useful Life Description Of Term Extensible Enumeration
PropertyPlantAndEquipmentUsefulLifeDescriptionOfTermExtensibleEnumeration
http://fasb.org/us-gaap/2023#LeaseholdImprovementsMember
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option Equity Instruments Warrants Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionEquityInstrumentsWarrantsExpired
shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Options Issued
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssued
shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
CY2022 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsGranted
shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
shares
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 dei Document Annual Report
DocumentAnnualReport
true
CY2023 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023 dei Security12g Title
Security12gTitle
Common Stock, $0.0001 par value
CY2023 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2023 dei Entity Voluntary Filers
EntityVoluntaryFilers
Yes
CY2023 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023 dei Entity Small Business
EntitySmallBusiness
true
CY2023 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023 dei Document Fin Stmt Error Correction Flag
DocumentFinStmtErrorCorrectionFlag
false
CY2023 dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Public Float
EntityPublicFloat
264438 usd
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
8814613 shares
CY2023 dei Auditor Firm
AuditorFirmId
822
CY2023 dei Auditor Name
AuditorName
Michael T. Studer CPA P.C.
CY2023 dei Auditor Location
AuditorLocation
Freeport, New York
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
318441 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
36616 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
75105 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13453 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
855633 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
170954 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
19912 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
22267 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1193986 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
229837 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
138494 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
179113 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
786062 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1024529 usd
CY2023Q4 us-gaap Deposits Assets
DepositsAssets
3000 usd
CY2022Q4 us-gaap Deposits Assets
DepositsAssets
7000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
927556 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1210642 usd
CY2023Q4 us-gaap Assets
Assets
2121542 usd
CY2022Q4 us-gaap Assets
Assets
1440479 usd
CY2023Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
575077 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
598251 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
971788 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
800818 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3028905 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3090211 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
265569 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
99869 usd
CY2023Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
102286 usd
CY2022Q4 us-gaap Deferred Compensation Liability Current
DeferredCompensationLiabilityCurrent
95429 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
200279 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
138173 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
62986 usd
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
62986 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
214702 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
112710 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5421592 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4998447 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5421592 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4998447 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3000000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
8814613 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
8814613 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1147827 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1147827 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
881 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
115 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 DGWR Preferred Stock Stated Value Per Share
PreferredStockStatedValuePerShare
1
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1440479 usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
52000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
52000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
9708646 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8761354 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13061577 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12371437 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3300050 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3557968 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2121542 usd
CY2023 us-gaap Officers Compensation
OfficersCompensation
1071425 usd
CY2022 us-gaap Officers Compensation
OfficersCompensation
271333 usd
CY2022 us-gaap Professional Fees
ProfessionalFees
103202 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
70827 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
23989 usd
CY2023 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
784855 usd
CY2022 us-gaap Other Selling General And Administrative Expense
OtherSellingGeneralAndAdministrativeExpense
751466 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
39039 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
44646 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
238467 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
247385 usd
CY2023 us-gaap Operating Expenses
OperatingExpenses
2305008 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
1442021 usd
CY2023 us-gaap Operating Income Loss
OperatingIncomeLoss
-259314 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-784238 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-101993 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1260501 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
200000 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1104017 usd
CY2023 us-gaap Interest Expense
InterestExpense
319966 usd
CY2022 us-gaap Interest Expense
InterestExpense
1224970 usd
CY2023 DGWR Gain Loss On Asset Disposal
GainLossOnAssetDisposal
45647 usd
CY2022 DGWR Gain Loss On Settlement Of Note Payable
GainLossOnSettlementOfNotePayable
11879 usd
CY2023 DGWR Gains Losses On Conversion Of Debt
GainsLossesOnConversionOfDebt
-54803 usd
CY2022 DGWR Gains Losses On Conversion Of Debt
GainsLossesOnConversionOfDebt
-453191 usd
CY2023 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
289 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4202 usd
CY2023 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-430826 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-409983 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-690140 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1194221 usd
CY2023 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.40
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.40
CY2023 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5055555 shares
CY2023 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5055555 shares
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
498288 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
498288 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4305579 usd
CY2022 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
28098 usd
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
460500 usd
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1432234 usd
CY2022 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
21000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3557968 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-3557968 usd
CY2023 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
60933 usd
CY2023 DGWR Stock Issued During Period Value Issuance Of Common Stock Incentives For Officers And Directors
StockIssuedDuringPeriodValueIssuanceOfCommonStockIncentivesForOfficersAndDirectors
705000 usd
CY2023 us-gaap Stock Issued During Period Value Employee Benefit Plan
StockIssuedDuringPeriodValueEmployeeBenefitPlan
149225 usd
CY2023 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
32900 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-690140 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3300050 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-3300050 usd
CY2023 us-gaap Net Income Loss
NetIncomeLoss
-690140 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-1194221 usd
CY2023 us-gaap Depreciation And Amortization
DepreciationAndAmortization
39039 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
44646 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
238467 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
247385 usd
CY2023 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
200000 usd
CY2022 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1104017 usd
CY2023 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-101993 usd
CY2022 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1260501 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
70827 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
23989 usd
CY2023 us-gaap Share Based Compensation
ShareBasedCompensation
854225 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
175431 usd
CY2023 DGWR Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
-54803 usd
CY2022 DGWR Gain Loss On Conversion Of Debt
GainLossOnConversionOfDebt
-453191 usd
CY2023 DGWR Gain Loss On Asset Disposal
GainLossOnAssetDisposal
45647 usd
CY2022 DGWR Gain Loss On Settlement Of Note Payable
GainLossOnSettlementOfNotePayable
11879 usd
CY2023 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
755506 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9041 usd
CY2023 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-2355 usd
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
13508 usd
CY2023 us-gaap Increase Decrease In Security Deposits
IncreaseDecreaseInSecurityDeposits
4000 usd
CY2023 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-55665 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8559 usd
CY2023 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
165700 usd
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
113152 usd
CY2023 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
6857 usd
CY2022 us-gaap Increase Decrease In Deferred Compensation
IncreaseDecreaseInDeferredCompensation
6622 usd
CY2023 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
62106 usd
CY2022 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
123382 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
253414 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-205894 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1964 usd
CY2023 us-gaap Proceeds From Sales Of Assets Investing Activities
ProceedsFromSalesOfAssetsInvestingActivities
51585 usd
CY2023 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
51585 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1964 usd
CY2023 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
500000 usd
CY2022 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
300000 usd
CY2023 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
500000 usd
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
140000 usd
CY2023 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-23174 usd
CY2022 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
47855 usd
CY2023 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-23174 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
207855 usd
CY2023 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
281825 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36616 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36619 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
318441 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
36616 usd
CY2023 us-gaap Interest Paid Net
InterestPaidNet
57860 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
2188 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1 usd
CY2023 DGWR Issuance Of Shares Series B Convertible Preferred Stock In Partial Satisfaction Of Note Payable To Ceo Shares
IssuanceOfSharesSeriesBConvertiblePreferredStockInPartialSatisfactionOfNotePayableToCeoShares
0 shares
CY2022 DGWR Issuance Of Shares Series B Convertible Preferred Stock In Partial Satisfaction Of Note Payable To Ceo Shares
IssuanceOfSharesSeriesBConvertiblePreferredStockInPartialSatisfactionOfNotePayableToCeoShares
21000 shares
CY2022 DGWR Issuance Of Series B Convertible Preferred Stock In Partial Satisfaction Of Note Payable To Ceo
IssuanceOfSeriesBConvertiblePreferredStockInPartialSatisfactionOfNotePayableToCeo
-21000 usd
CY2022 DGWR Issuance Of Common Stock To Officers For Accrued Compensation
IssuanceOfCommonStockToOfficersForAccruedCompensation
231150 usd
CY2022 DGWR Issuance Of Common Stock In Satisfaction Of Loans Payable To Officers
IssuanceOfCommonStockInSatisfactionOfLoansPayableToOfficers
82511 usd
CY2022 DGWR Issuance Of Common Stock In Satisfaction Of Deferred Compensation
IssuanceOfCommonStockInSatisfactionOfDeferredCompensation
3739 usd
CY2022 DGWR Due To Seller Of Lyell Recognized And Added To Goodwill
DueToSellerOfLyellRecognizedAndAddedToGoodwill
48749 usd
CY2023 DGWR Conversions Of Convertible Notes Payable Principal
ConversionsOfConvertibleNotesPayablePrincipal
29030 usd
CY2022 DGWR Conversions Of Convertible Notes Payable Principal
ConversionsOfConvertibleNotesPayablePrincipal
900173 usd
CY2022 DGWR Accrued Interest And Charges
AccruedInterestAndCharges
78870 usd
CY2023 us-gaap Notes Assumed1
NotesAssumed1
29030 usd
CY2022 us-gaap Notes Assumed1
NotesAssumed1
979043 usd
CY2023 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
116318 shares
CY2022 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
564256 shares
CY2023 DGWR Fair Value Of And Shares Respectively Issued To Lenders
FairValueOfAndSharesRespectivelyIssuedToLenders
60933 usd
CY2022 DGWR Fair Value Of And Shares Respectively Issued To Lenders
FairValueOfAndSharesRespectivelyIssuedToLenders
1432234 usd
CY2023 DGWR Loss On Conversions Of Convertible Notes Payable
LossOnConversionsOfConvertibleNotesPayable
31903 usd
CY2022 DGWR Loss On Conversions Of Convertible Notes Payable
LossOnConversionsOfConvertibleNotesPayable
453191 usd
CY2023 DGWR Fair Value Of Shares Of Common Stock Issued
FairValueOfSharesOfCommonStockIssued
32900 usd
CY2023 DGWR Accounts Payable Satisfied
AccountsPayableSatisfied
-10000 usd
CY2023 DGWR Loss On Satisfaction Of Accounts Payable
LossOnSatisfactionOfAccountsPayable
22900 usd
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 1,500
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
598251 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
575077 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
598251 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
575077 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
598251 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
971788 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
800818 usd
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
971788 usd
CY2022Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
800818 usd
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P5Y
CY2023 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zoCSlzwFUBk9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_866_zlXk4YJ6ltf8">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenue and expenses during the reporting periods. Actual results could differ from those estimates.</span></p>
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
357445 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
370254 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
357445 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
370254 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
218951 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
191141 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
138494 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
179113 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1327259 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1327259 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1327259 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
1327259 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
541197 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
302730 usd
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
786062 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
1024529 usd
CY2023 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P5Y
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
238467 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
238467 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
174202 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
651136 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3028905 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3090211 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3028905 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3090211 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
575077 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
214702 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
112710 usd
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
214702 usd
CY2022Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
112710 usd
CY2023Q2 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 1,500
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7270000 shares
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
854225 usd
CY2023Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7270000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
53 shares
CY2020Q4 DGWR Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingNumber
53 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations
20 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsExpired
-20 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Warrant Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWarrantExpired
33 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Expired Two
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsExpiredTwo
-33 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
3333 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsGranted
3333 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
3333 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsExercised
3333 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Issued
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsIssued
88889 shares
CY2021 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Issued
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsIssued
88889 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
88889 shares
CY2021Q4 DGWR Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingNumber
88889 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
88889 shares
CY2022Q4 DGWR Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingNumber
88889 shares
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
44444 shares
CY2023 DGWR Share Based Compensation Arrangement By Share Based Payment Award Option And Warrants Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionAndWarrantsGranted
-44444 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
44445 shares
CY2023Q4 DGWR Share Based Compensation Arrangement By Share Based Payment Award Options And Warrants Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAndWarrantsOutstandingNumber
44445 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
44445 shares
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2023 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.21 pure
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-144929 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-250786 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
179387 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
36841 usd
CY2023 DGWR Income Tax Reconciliation Nontaxable Derivative Liability Expense
IncomeTaxReconciliationNontaxableDerivativeLiabilityExpense
-21419 usd
CY2022 DGWR Income Tax Reconciliation Nontaxable Derivative Liability Expense
IncomeTaxReconciliationNontaxableDerivativeLiabilityExpense
264705 usd
CY2023 DGWR Nondeductible Loss On Conversions Of Convertible Notes Payable
NondeductibleLossOnConversionsOfConvertibleNotesPayable
-11509 usd
CY2022 DGWR Nondeductible Loss On Conversions Of Convertible Notes Payable
NondeductibleLossOnConversionsOfConvertibleNotesPayable
-95170 usd
CY2023 us-gaap Income Tax Reconciliation Nondeductible Expense Depreciation And Amortization
IncomeTaxReconciliationNondeductibleExpenseDepreciationAndAmortization
2625 usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Depreciation And Amortization
IncomeTaxReconciliationNondeductibleExpenseDepreciationAndAmortization
231844 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-70011 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
151636 usd
CY2023 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1 pure
CY2023 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
The net operating loss carryforward at December 31, 2023 for the years 2004 to 2017 expires in varying amounts from year 2024 to year 2037.
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
318441 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1193986 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5421592 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13061577 usd
CY2023 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
253414 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-205894 usd
CY2023Q4 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q4 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q4 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001493152-24-015461-index-headers.html Edgar Link pending
0001493152-24-015461-index.html Edgar Link pending
0001493152-24-015461.txt Edgar Link pending
0001493152-24-015461-xbrl.zip Edgar Link pending
dgwr-20231231.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
dgwr-20231231_cal.xml Edgar Link unprocessable
dgwr-20231231_def.xml Edgar Link unprocessable
dgwr-20231231_lab.xml Edgar Link unprocessable
dgwr-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-k_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending